liarozole

An orally-active benzimidazole derivative with potential antineoplastic activity. As a retinoic acid metabolism blocking agent, liarozole inhibits… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2017
051019922017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
OBJECTIVE To investigate the impact of liarozole on transforming growth factor-β3 (TGF-β3) expression, TGF-β3 controlled… (More)
Is this relevant?
2012
2012
OBJECTIVE To study the influence of liarozole on leiomyoma cell proliferation and extracellular matrix (ECM) gene expression in… (More)
Is this relevant?
2001
2001
BACKGROUND Palmoplantar pustular psoriasis (PPP) is a chronic, relapsing condition often recalcitrant to therapy. Synthetic… (More)
Is this relevant?
1999
1999
1Alpha,25-dihydroxyvitamin D3 [1,25-(OH)2D3] inhibits the proliferation of many cancer cells in culture, but not the aggressive… (More)
Is this relevant?
1998
1998
OBJECTIVES To compare the efficacy of oral liarozole, the first retinoic acid metabolism-blocking agent (RAMBA) to be developed… (More)
Is this relevant?
1997
1997
Liarozole, a novel imidazole derivative, inhibits the cytochrome P450-dependent 4-hydroxylation of retinoic acid, resulting in… (More)
Is this relevant?
1996
1996
Beta-carotene, canthaxanthin and retinoic acid (RA) inhibited growth of human DU145 prostate cancer cells by 45, 56 and 18… (More)
Is this relevant?
1994
1994
Continuous oral dosing with all-trans retinoic acid (RA) is associated with a progressive decrease in plasma drug concentrations… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1994
1994
The metabolism of 4-keto-all-trans-retinoic-acid (4-keto-RA), a biologically active oxygenated metabolite of all-trans-retinoic… (More)
Is this relevant?
1992
1992
Liarozole is an imidazole-containing compound that inhibits the cytochrome P-450-dependent metabolism of all-trans-retinoic acid… (More)
Is this relevant?